GLENMARK PHARMACEUTICALS LIMITED

Active    As on: 17 June, 2024    Update Info    Print    Share

OVERVIEW - GLENMARK PHARMACEUTICALS LIMITED

Glenmark Pharmaceuticals Limited is a listed public company incorporated on 18 November, 1977. It is classified as a public limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 277.00 cr and the total paid-up capital is INR 28.22 cr.

Glenmark Pharmaceuticals Limited's operating revenues range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by -12.76 % over the previous year. At the same time, it's book networth has increased by 6.80 %. Other performance and liquidity ratios are available here.

Description: The company develops, manufactures, and markets pharmaceutical products in India, the United States, Latin America, Europe, and internationally. The company provides branded and generic formulations in therapeutic areas of dermatology, respiratory, and oncology.

Products & Services: GBR 1302 for breast and gastric cancer; GBR 1342 for multiple myeloma; GBR 1372 for colorectal cancer; GBR 830 for atopic dermatitis; GRC 39815 for COPD and IPF; Ryaltris for allergic rhinitis; GSP 304 for COPD; GBR 310 for Asthma and CIU; and GRC 27864 for chronic pain indications
Category: Manufacturer

The current status of Glenmark Pharmaceuticals Limited is - Active.

The last reported AGM (Annual General Meeting) of Glenmark Pharmaceuticals Limited, per our records, was held on 29 September, 2023.

Glenmark Pharmaceuticals Limited has eight directors - Blanche Saldanha Elizabeth, Rajesh Vasudeo Desai, and others.

The Corporate Identification Number (CIN) of Glenmark Pharmaceuticals Limited is L24299MH1977PLC019982. The registered office of Glenmark Pharmaceuticals Limited is at B-2MAHALAXMI CHAMBERS22 BHULABHAI DESAI ROAD MAHALAXMI NA, , MUMBAI, Maharashtra.

  • COMPANY FINANCIALS
  • INR 349
    Company360 is an interactive dashboard that provides more than 3 years company’s financials, ratios, charts, network and features like lists, comparator, financial alerts, pdf reports, and excel downloads.
    Learn More
  • INR 349
    All financials and shareholder returns available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249
    Latest Balance Sheet, Profit and Loss# and shareholder return available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • INR 2999
    A pdf report that includes standalone and consolidated financials, risk analysis, cashflows, capital infusion details, litigation, credit ratings, group structure, GST details, Competition analysis and more.
    Delivery time: 2 working days (Mon-Fri).
    View a Sample Report
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
    *** Working hours: 9am-6pm (Mon-Fri)

Company360 plans

360lite-screenshot

Know more about your vendors, clients and competitors.


Financials, scores, ratios, excels, reports and more.

@ INR 9000/quarter

take free trial

Join our newsletter

For business and industry related insights, twice in a month. No spam.

Check out our latest blogs:

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Demystifying Supply Chain Challenges: A Practical Guide

In the intricate world of supply chain management, companies face a......

read more

REGISTERED DETAILS - GLENMARK PHARMACEUTICALS LIMITED


CIN

L24299MH1977PLC019982

Incorporation Date / Age

18 November, 1977 / 47 yrs

Last Reported AGM Date

29 September, 2023


Authorized Capital

INR 27700.0 Lacs

Paidup Capital

INR 2821.88156 Lacs

industry*

Manufacturing (Chemicals and chemical products)


type

Listed Public Company

category

Company limited by Shares

subcategory

Non-govt company


Email Address

Login for email address. This is to prevent spam.

Website

http://www.glenmarkpharma.com. (Incorrect website?)

Registered Address

B-2MAHALAXMI CHAMBERS22 BHULABHAI DESAI ROAD MAHALAXMI NA

MUMBAI - 400026
Maharashtra - India


How to download GLENMARK PHARMACEUTICALS LIMITED report

A Company report by Tofler is an easy-to-read PDF report that includes company's financial information, ratio analysis, management, group structure, shareholding pattern and more. Such reports can be bought from company pages at Tofler (Sample) or can be downloaded from Company360. Here is the video showing how a report downloaded from Company360 looks like.

GLENMARK PHARMACEUTICALS LIMITED - Registration Details
CINL24299MH1977PLC019982
Incorporation Date / Age18 November, 1977 / 47 yrs
Last Reported AGM Date29 September, 2023
Authorized CapitalINR 27700.0 Lacs
Paidup CapitalINR 2821.88156 Lacs
industry*Manufacturing (Chemicals and chemical products)
typeListed Public Company
categoryCompany limited by Shares
subcategoryNon-govt company
Email Address
Websitehttp://www.glenmarkpharma.com
Registered AddressB-2MAHALAXMI CHAMBERS22 BHULABHAI DESAI ROAD MAHALAXMI NA  MUMBAI - 400026 Maharashtra - India

FINANCIAL HIGHLIGHTS - GLENMARK PHARMACEUTICALS LIMITED

Provided here are the financial indicators for financial year ending on 31 March, 2023. Actual numbers and updated financial data are included in purchased financial report.
View Sample Report.
Operating Revenue Over INR 500 cr
EBITDA -12.76 %
Networth 6.80 %
Debt/Equity Ratio 0.18
Return on Equity 6.76 %

* Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.

How to get financial reports of GLENMARK PHARMACEUTICALS LIMITED

Tofler Company360 provides access to any Indian company's financial documents, charts, ratio analysis and more. It lets you compare financials of several companies and study performance trends. These financials can also be downloaded in excel format. Here is the video showing how you can study the financials of an Indian company on the Company360 platform.

Directors - GLENMARK PHARMACEUTICALS LIMITED

The company has 8 directors and 2 reported key management personnel.


The longest serving director currently on board is Glenn Mario Saldanha who was appointed on 12 October, 1998. Glenn Mario Saldanha has been on the board for more than 25 years. The most recently appointed director is Vijayalakshmi Iyer, who was appointed on 14 April, 2023.


Vijayalakshmi Iyer has the largest number of other directorships with a seat at a total of 11 companies. In total, the company is connected to 16 other companies through its directors.


NAME DESIGNATION APPOINTMENT DATE
BLANCHE SALDANHA ELIZABETH Director 14 August, 2009 Other directorships - GM PHARMA LIMITED,  GLENMARK ACCESS LIMITED, 
RAJESH VASUDEO DESAI Director 16 May, 2002 Other directorships - GLENMARK GENERICS LIMITED,  DESVEN CONSULTANTS PRIVATE LIMITED,  QI LIFECARE PRIVATE LIMITED CN, 
GLENN MARIO SALDANHA Director 12 October, 1998 Other directorships - GM PHARMA LIMITED,  GLENMARK GENERICS LIMITED,  GLENMARK ACCESS LIMITED,  GLENMARK HEALTHCARE LIMITED, 
CHERYLANN MARIA PINTO Director 16 May, 2007 Other directorships - GLENMARK ACCESS LIMITED,  GLENMARK HEALTHCARE LIMITED, 
V S MANI KMP 16 November, 2017 No other directorships
V S MANI Director 29 May, 2018 Other directorships - GLENMARK HEALTHCARE LIMITED, 
VIJAYALAKSHMI IYER Director 14 April, 2023 Other directorships - BFSI SECTOR SKILL COUNCIL OF INDIA,  AXIS MUTUAL FUND TRUSTEE LIMITED,  GAWAR INVESTMENT MANAGER PRIVATE LIMITED,  ICICI SECURITIES LIMITED,  L&T INFRASTRUCTURE DEVELOPMENT PROJECTS LIMITED,  COMPUTER AGE MANAGEMENT SERVICES LIMITED,  AVANSE FINANCIAL SERVICES LIMITED,  CG POWER AND INDUSTRIAL SOLUTIONS LIMITED,  L&T METRO RAIL (HYDERABAD) LIMITED,  ADITYA BIRLA CAPITAL LIMITED, 
SONA SAIRA RAMASASTRY Director 01 April, 2019 No other directorships
DIPANKAR BHATTACHARJEE Director 14 August, 2020 No other directorships
HARISH VINAYAK KUBER KMP 02 February, 2017 No other directorships
NAME DESIGNATION APPOINTMENT DATE
BLANCHE SALDANHA ELIZABETH Director 14 August, 2009 View other directorships
RAJESH VASUDEO DESAI Director 16 May, 2002 View other directorships
GLENN MARIO SALDANHA Director 12 October, 1998 View other directorships
CHERYLANN MARIA PINTO Director 16 May, 2007 View other directorships
V S MANI KMP 16 November, 2017 No other directorships
V S MANI Director 29 May, 2018 View other directorships
VIJAYALAKSHMI IYER Director 14 April, 2023 View other directorships
SONA SAIRA RAMASASTRY Director 01 April, 2019 No other directorships
DIPANKAR BHATTACHARJEE Director 14 August, 2020 No other directorships
HARISH VINAYAK KUBER KMP 02 February, 2017 No other directorships
12 October, 1998
16 May, 2002
16 May, 2007
14 August, 2009
02 February, 2017

HARISH VINAYAK KUBER

KMP

16 November, 2017

V S MANI

KMP

29 May, 2018

V S MANI

Director

01 April, 2019
14 August, 2020
14 April, 2023

Bank-wise Biggest Charges on Assets

See more...

Previous Names

No previous names were found for this company.

Previous CINs

No previous CINs were found for this company.

SIMILAR COMPANIES

NAME INCORPORATION YEAR STATE PAID UP CAPITAL
MANEESH PHARMACEUTICALS LIMITED It was formed in year 1985 in Maharashtra . The company currently has a paid up capital of INR 28.13 cr.
1985 Maharashtra 28.13 cr Buy financial reports
ALKA LABORATORIES PRIVATE LIMITED It was formed in year 1998 in Delhi . The company currently has a paid up capital of INR 28.08 cr.
1998 Delhi 28.08 cr Buy financial reports
COASTAL BIOTECH PRIVATE LIMITED It was formed in year 2021 in Orissa . The company currently has a paid up capital of INR 28.00 cr.
2021 Orissa 28.00 cr Buy financial reports
SIRIS LIMITED It was formed in year 1966 in Andhra Pradesh . The company currently has a paid up capital of INR 28.00 cr.
1966 Andhra Pradesh 28.00 cr Buy financial reports
LUBRIZOL MANUFACTURING INDIA PRIVATE LIMITED It was formed in year 2020 in Maharashtra . The company currently has a paid up capital of INR 28.00 cr.
2020 Maharashtra 28.00 cr Buy financial reports
O2 CHEMICALS PRIVATE LIMITED It was formed in year 2021 in West Bengal . The company currently has a paid up capital of INR 28.46 cr.
2021 West Bengal 28.46 cr Buy financial reports
GENNEX LABORATORIES LIMITED It was formed in year 1990 in Telangana . The company currently has a paid up capital of INR 28.46 cr.
1990 Telangana 28.46 cr Buy financial reports
DCM NOUVELLE SPECIALTY CHEMICALS LIMITED It was formed in year 2022 in Delhi . The company currently has a paid up capital of INR 28.47 cr.
2022 Delhi 28.47 cr Buy financial reports
VOVANTIS LABORATORIES PRIVATE LIMITED It was formed in year 2008 in Gujarat . The company currently has a paid up capital of INR 28.50 cr.
2008 Gujarat 28.50 cr Buy financial reports
MOMENTIVE PERFORMANCE MATERIALS (INDIA) PRIVATE LIMITED It was formed in year 1995 in Karnataka . The company currently has a paid up capital of INR 28.63 cr.
1995 Karnataka 28.63 cr Buy financial reports

SUBSIDIARY COMPANIES

No Indian subsidiary companies found.

Company Network - GLENMARK PHARMACEUTICALS LIMITED

Company Network • Tofler Business Research Platform
How to use company network of GLENMARK PHARMACEUTICALS LIMITED

Tofler Company network is a powerful feature that allows you to explore and discover common directorships between companies. It helps you find out other directorships of an Indian director and where else he has business interests. The feature is available for unlimited use in Company360 platform. Here is the video showing how you can explore company networks to discover hidden relationships between companies.

FAQ - GLENMARK PHARMACEUTICALS LIMITED

  • What is the Incorporation date of GLENMARK PHARMACEUTICALS LIMITED?

    The Incorporation Date of GLENMARK PHARMACEUTICALS LIMITED is 18 November, 1977.

  • What is the operating revenue of GLENMARK PHARMACEUTICALS LIMITED?

    The operating revenue of GLENMARK PHARMACEUTICALS LIMITED is in the range of Over INR 500 cr for the financial year ending on 31 March, 2023.

  • What is the change in EBITDA of GLENMARK PHARMACEUTICALS LIMITED since last year?

    The EBITDA of GLENMARK PHARMACEUTICALS LIMITED has decreased by -12.76 % over the previous year. At the same time, it's book networth has increased by 6.80 % for the financial year ending 31 March, 2023.

  • What is the business of GLENMARK PHARMACEUTICALS LIMITED?

    The company develops, manufactures, and markets pharmaceutical products in India, the United States, Latin America, Europe, and internationally. The company provides branded and generic formulations in therapeutic areas of dermatology, respiratory, and oncology..

  • Which Products and Services are provided by GLENMARK PHARMACEUTICALS LIMITED?

    The products and services offered by GLENMARK PHARMACEUTICALS LIMITED are GBR 1302 for breast and gastric cancer; GBR 1342 for multiple myeloma; GBR 1372 for colorectal cancer; GBR 830 for atopic dermatitis; GRC 39815 for COPD and IPF; Ryaltris for allergic rhinitis; GSP 304 for COPD; GBR 310 for Asthma and CIU; and GRC 27864 for chronic pain indications.

  • Who are the directors of GLENMARK PHARMACEUTICALS LIMITED?

    Glenmark Pharmaceuticals Limited has eight directors - Blanche Saldanha Elizabeth, Rajesh Vasudeo Desai, and others.

  • COMPANY FINANCIALS
  • INR 349
    Company360 is an interactive dashboard that provides more than 3 years company’s financials, ratios, charts, network and features like lists, comparator, financial alerts, pdf reports, and excel downloads.
    Learn More
  • INR 349
    All financials and shareholder returns available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 249
    Latest Balance Sheet, Profit and Loss# and shareholder return available at MCA for download along with latest MoA and AoA.
    Delivery time: 8 working hours (Mon-Fri).
  • INR 799
    An easy-to-read PDF report on the company that includes five year financial information, ratio analysis, management, group structure, shareholding pattern and more.
    Delivery time: 1 working day (Mon-Fri).
    View a Sample Report
  • INR 2999
    A pdf report that includes standalone and consolidated financials, risk analysis, cashflows, capital infusion details, litigation, credit ratings, group structure, GST details, Competition analysis and more.
    Delivery time: 2 working days (Mon-Fri).
    View a Sample Report
  • # Wherever available
    * Prices are exclusive of taxes.
    ** Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
    *** Working hours: 9am-6pm (Mon-Fri)

Company360 plans

360lite-screenshot

Know more about your vendors, clients and competitors.


Financials, scores, ratios, excels, reports and more.

@ INR 9000/quarter

take free trial

Join our newsletter

For business and industry related insights, twice in a month. No spam.

Check out our latest blogs:

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Unlocking the Essentials: Exploring the Basic Elements of Supply Chain Management

In today's bustling world of commerce, understanding the fundamental......

read more

Demystifying Supply Chain Challenges: A Practical Guide

In the intricate world of supply chain management, companies face a......

read more



Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More